Kukje Pharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 12, 2021 at 11:49 am IST
Share
Kukje Pharma Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 29,833.84 million compared to KRW 33,493.78 million a year ago. Net income was KRW 806.26 million compared to KRW 669.39 million a year ago. Basic earnings per share from continuing operations was KRW 41.9048 compared to KRW 34.2857 a year ago. Diluted earnings per share from continuing operations was KRW 41.9048 compared to KRW 34.2857 a year ago. Basic earnings per share was KRW 41.9048 compared to KRW 34.2857 a year ago.
For the nine months, sales was KRW 86,844.39 million compared to KRW 102,149.41 million a year ago. Net income was KRW 1,785.35 million compared to KRW 5,870.66 million a year ago. Basic earnings per share from continuing operations was KRW 92.381 compared to KRW 303.8095 a year ago. Diluted earnings per share from continuing operations was KRW 92.381 compared to KRW 303.8095 a year ago. Basic earnings per share was KRW 92.381 compared to KRW 303.8095 a year ago.
Kukje Pharma Co., Ltd, formerly Kukje Pharma Ind. Co., Ltd, is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products are finished products, such as antibiotics, other antibiotics for injection, antifungal and antiviral agents, agents for gastrointestinal tract and liver, muscle relaxants, anti-osteoporotics, corticosteroids, agents for cardiovascular and endocrine systems, ophthalmic agents, remedies for central nervous system (CNS) disorders, remedies for urinary systems, antihistamines, antitussives, cough and cold remedies, non-steroidal anti inflammatory drugs (NSAIDs), antitussive, cough and cold remedies, as well as other over-the-counter (OTC) drugs. It also provides raw materials, such as ceftriaxone sodium sterile, cefuroxime axetil, ceftezole sodium sterile, cefminox sodium sterile, cefuroxime sodium sterile and others.